Trisubstituted 1,2,4-triazoles

Details for Australian Patent Application No. 2008313776 (hide)

Owner Janssen Pharmaceutica NV

Inventors Dinklo, Theodorus; Lesage, Anne Simone Josephine; Thuring, Johannes Wilhelmus John F.; Zhuang, Wei; De Bruyn, Marcel Frans Leopold

Agent Shelston IP

Pub. Number AU-A-2008313776

PCT Pub. Number WO2009/050186

Priority 07118825.4 18.10.07 EP

Filing date 15 October 2008

Wipo publication date 23 April 2009

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/050186 Priority application(s): WO2009/050186

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008313788-Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases

2008313775-1,3,5-trisubstituted triazole derivative